GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
GSK's price to sales ratio was 2.4× on Oct 19, 2026, against 2.4× a year earlier. Over the last 5 years it ranged from 1.8× to 3.6×, with a median of 2.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 2.4× | −0.1 |
| 2025 | Dec 31, 2025 | 2.4× | +0.6 |
| 2024 | Dec 31, 2024 | 1.8× | −0.2 |
| 2023 | Dec 29, 2023 | 2.0× | −0.4 |
| 2022 | Dec 30, 2022 | 2.4× | −0.9 |
| 2021 | Dec 31, 2021 | 3.3× | +1.4 |
| 2020 | Dec 31, 2020 | 2.0× | −0.8 |
| 2019 | Dec 31, 2019 | 2.8× | +0.4 |
| 2018 | Dec 31, 2018 | 2.4× | +0.1 |
| 2017 | Dec 29, 2017 | 2.3× | −0.9 |
| 2016 | Dec 30, 2016 | 3.1× | – |